{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:21:12Z","timestamp":1648743672158},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.transproceed.2009.02.003","type":"journal-article","created":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T08:38:34Z","timestamp":1240043914000},"page":"959-961","source":"Crossref","is-referenced-by-count":2,"title":["Mucosa-Associated Lymphoid Tissue Gastric Lymphoma Regression in a Renal Transplant Patient After Conversion of the Immunosuppression to Sirolimus: A Case Report"],"prefix":"10.1016","volume":"41","author":[{"given":"E.P.","family":"Lasmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.V.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Lasmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.F.","family":"Lasmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.V.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.02.003_bib1","series-title":"The Non-Hodgkin's Lymphomas","first-page":"171","article-title":"Epidemiology of non-Hodgkin's lymphomas","author":"Rabkin","year":"1997"},{"key":"10.1016\/j.transproceed.2009.02.003_bib2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.02.003_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2559.1996.292338.x","article-title":"Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients","volume":"28","author":"Wotherspoon","year":"1996","journal-title":"Histopathology"},{"issue":"suppl","key":"10.1016\/j.transproceed.2009.02.003_bib4","first-page":"5477S","article-title":"Lymphoma risks in populations with altered immunity\u2014a search for mechanism","volume":"52","author":"Hoover","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2009.02.003_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy","volume":"53","author":"Fischback","year":"2004","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2009.02.003_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-5378.7.s1.6.x","article-title":"Helicobacter pylori and gastric malignancies","volume":"7","author":"Sepulveda","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.transproceed.2009.02.003_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1432-2277.2005.00134.x","article-title":"Gastrointestinal complications in renal transplant recipients","volume":"18","author":"Ponticelli","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2009.02.003_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/157488707780599366","article-title":"Clinical development of mTOR inhibitors: a focus on lymphoma","volume":"2","author":"Smith","year":"2007","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.transproceed.2009.02.003_bib9","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","article-title":"mTOR and cancer therapy","volume":"25","author":"Easton","year":"2006","journal-title":"Oncogene"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T11:51:47Z","timestamp":1545306707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0041134509001407"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.02.003","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}